TY - JOUR
AU1 - Shively, Bruce
AU2 - Goldschlager, Nora
AB - Abstract Cardiac pacing therapy has evolved rapidly since the first device was implanted 26 years ago.1 Technologic progress has provided the clinician with microprocessor-based multiprogrammable pulse generators, long-lived power sources, and reliable atrial and ventricular lead systems. Along with these developments, the indications for singleand dual-chamber pacing have broadened considerably since the early pacemakers were implanted for complete heart block. They now include the bradyarrhythmic manifestations of the sick sinus syndrome and some types of tachycardias.2-4 As a result, the number of patients in the United States with pacemakers is over 500,000 and growing.5 The practicing physician is thus very likely to encounter patients who either have or need a pacing system. In the past, the physician caring for a patient was concerned primarily with establishing the indications for pacemaker implantation. Now pacing therapy must be individualized to match the patient's needs with the most suitable pacing mode References 1. Elmqvist R, Landegren J, Petterson SO, et al: Artificial pacemaker for treatment of Adams-Stokes syndrome and slow heart rate. Am Heart J 1963;65:731-748.Crossref 2. Phibbs B, Friedman HS, Graboys TB, et al: Indications for pacing in the treatment of bradyarrhythmias. JAMA 1984;252:1307-1311.Crossref 3. Joint American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommittee on Pacemaker Implantation): Guidelines for permanent cardiac pacemaker implantation, May 1984. J Am Coll Cardiol 1984;4:434-442.Crossref 4. Castellanos A, Waxman HL, Berkovits BV, et al: Implantable pacemakers for cardiac tachyarrhythmias. Cardiovasc Clin 1980;11:159-173. 5. Parsonnet V, Furman S, Smyth NPD, et al: Otpimal resources for implantable cardiac pacemakers. Circulation 1981;68:227A-244A. 6. Billhardt RA, Rosenbush SW, Hauser RG: Successful management of pacing system malfunctions without surgery: The role of programmable pulse generators. PACE 1982;5:675-682.Crossref 7. Parsonnet V, Rodgers T: The present status of programmable pacemakers. Prog Cardiovasc Dis 1981;23:401-420.Crossref 8. Harthorne J: Programmable pacemakers: Technical features and clinical applications. Cardiovasc Clin 1983;14:135-147. 9. Levine PA, Klein MD: Myopotential inhibition of unipolar pacemakers: A disease of technologic progress. Ann Intern Med 1983;98:101-103.Crossref 10. Fetter J, Bobeldyk GL, Engman FJ: The clinical incidence and significance of myopotential sensing with unipolar pacemakers. PACE 1984;7:871-881.Crossref 11. Parsonnet V, Bernstein AD: Cardiac pacing in the 1980s: Treatment and techniques in transition. J Am Coll Cardiol 1983;1:339-354.Crossref 12. Bhatt S, Schober RC: Holter monitoring using implanted pacemakers , in Barold SS, Mugica J (eds): The Third Decade of Cardiac Pacing: Advances in Technology and Clinical Applications . Mount Kisco, NY, Futura Publishing Co Inc, 1982, pp 333-344. 13. Mirowski M, Reid PR, Mower MM, et al: The automatic implantable cardioverter-defibrillator. PACE 1984;7:534-540.Crossref
TI - Progress in Cardiac Pacing: Part I
JF - Archives of Internal Medicine
DO - 10.1001/archinte.1985.00360110179035
DA - 1985-11-01
UR - https://www.deepdyve.com/lp/american-medical-association/progress-in-cardiac-pacing-part-i-EwXyLOs2Vy
SP - 2103
EP - 2106
VL - 145
IS - 11
DP - DeepDyve
ER -